Ross Levine, MD, on Clonal Evolution in “MSK Science Spotlight”

Ross L. Levine, MD

Ross L. Levine, MD

The May 6 session of “MSK Science Spotlight” features Ross Levine, MD, Laurence Joseph Dineen Chair in Leukemia Research and Chief, Molecular Cancer Medicine Service, Human Oncology and Pathogenesis Program, presenting his work on “Deciphering and Targeting Clonal Evolution.” The focus of the Levine Lab’s work is to improve understanding of the genetic basis of blood disorders known as myeloid malignancies, and to use this knowledge to improve therapies for patients with these disorders.

MSK Science Spotlight
“MSK Science Spotlight” seminars take place every Monday and Wednesday at ET and will last 60 minutes, including 15 minutes for Q&A. Detailed information about seminar speakers, dates, and times as well as live streams and recorded video are available here